AARTI PHARMALABS
|
AARTI PHARMALABS Last 5 Year Balance Sheet History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹45 Cr | ₹45 Cr | ₹45 Cr | ₹0.25 Cr | ₹0.25 Cr |
| Equity - Authorised | ₹50 Cr | ₹50 Cr | ₹50 Cr | ₹0.50 Cr | ₹0.50 Cr |
| Equity - Issued | ₹45 Cr | ₹45 Cr | ₹45 Cr | ₹0.25 Cr | ₹0.25 Cr |
| Equity Paid Up | ₹45 Cr | ₹45 Cr | ₹45 Cr | ₹0.25 Cr | ₹0.25 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹5.00 | ₹5.00 | ₹5.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | ₹1.73 Cr | ₹0.23 Cr | - | ₹45 Cr | - |
| Total Reserves | ₹1,943 Cr | ₹1,711 Cr | ₹1,513 Cr | ₹1,341 Cr | ₹-0.02 Cr |
| Securities Premium | ₹441 Cr | ₹440 Cr | ₹440 Cr | ₹440 Cr | - |
| Capital Reserves | ₹89 Cr | ₹89 Cr | ₹89 Cr | ₹89 Cr | - |
| Profit & Loss Account Balance | ₹1,323 Cr | ₹1,086 Cr | ₹889 Cr | ₹717 Cr | ₹-0.02 Cr |
| General Reserves | ₹90 Cr | ₹88 Cr | ₹85 Cr | ₹83 Cr | - |
| Other Reserves | ₹-0.48 Cr | ₹8.32 Cr | ₹8.77 Cr | ₹11 Cr | - |
| Reserve excluding Revaluation Reserve | ₹1,943 Cr | ₹1,711 Cr | ₹1,513 Cr | ₹1,341 Cr | ₹-0.02 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹1,990 Cr | ₹1,757 Cr | ₹1,558 Cr | ₹1,386 Cr | ₹0.23 Cr |
| Minority Interest | - | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | ₹104 Cr | ₹0.04 Cr | ₹0.18 Cr | ₹0.56 Cr | - |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | ₹104 Cr | - | - | - | - |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | ₹0.04 Cr | ₹0.18 Cr | ₹0.56 Cr | - |
| Unsecured Loans | - | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹128 Cr | ₹108 Cr | ₹79 Cr | ₹71 Cr | - |
| Deferred Tax Assets | ₹4.08 Cr | ₹2.31 Cr | ₹1.95 Cr | - | - |
| Deferred Tax Liability | ₹132 Cr | ₹110 Cr | ₹81 Cr | ₹71 Cr | - |
| Other Long Term Liabilities | ₹19 Cr | ₹17 Cr | ₹0.53 Cr | ₹1.53 Cr | - |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹8.12 Cr | ₹6.06 Cr | ₹5.36 Cr | - | - |
| Total Non-Current Liabilities | ₹259 Cr | ₹131 Cr | ₹85 Cr | ₹73 Cr | - |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹278 Cr | ₹378 Cr | ₹340 Cr | ₹215 Cr | ₹0.00 Cr |
| Sundry Creditors | ₹278 Cr | ₹378 Cr | ₹340 Cr | ₹215 Cr | ₹0.00 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹74 Cr | ₹46 Cr | ₹38 Cr | ₹12 Cr | ₹0.00 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹14 Cr | ₹5.63 Cr | ₹10 Cr | - | - |
| Interest Accrued But Not Due | - | - | - | - | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹60 Cr | ₹40 Cr | ₹28 Cr | ₹12 Cr | ₹0.00 Cr |
| Short Term Borrowings | ₹293 Cr | ₹264 Cr | ₹214 Cr | ₹338 Cr | ₹0.02 Cr |
| Secured ST Loans repayable on Demands | ₹293 Cr | ₹264 Cr | ₹193 Cr | ₹13 Cr | - |
| Working Capital Loans- Sec | ₹293 Cr | ₹264 Cr | ₹193 Cr | ₹13 Cr | - |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹-293 Cr | ₹-264 Cr | ₹-172 Cr | ₹312 Cr | ₹0.02 Cr |
| Short Term Provisions | ₹13 Cr | ₹6.31 Cr | ₹9.01 Cr | ₹16 Cr | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹1.15 Cr | - | ₹3.52 Cr | ₹7.50 Cr | - |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹12 Cr | ₹6.31 Cr | ₹5.50 Cr | ₹8.96 Cr | - |
| Total Current Liabilities | ₹657 Cr | ₹694 Cr | ₹601 Cr | ₹581 Cr | ₹0.02 Cr |
| Total Liabilities | ₹2,906 Cr | ₹2,582 Cr | ₹2,244 Cr | ₹2,040 Cr | ₹0.25 Cr |
| ASSETS | |||||
| Gross Block | ₹1,796 Cr | ₹1,609 Cr | ₹1,431 Cr | ₹1,225 Cr | - |
| Less: Accumulated Depreciation | ₹659 Cr | ₹576 Cr | ₹505 Cr | ₹443 Cr | - |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹1,137 Cr | ₹1,033 Cr | ₹926 Cr | ₹782 Cr | - |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹307 Cr | ₹78 Cr | ₹62 Cr | ₹165 Cr | - |
| Non Current Investments | ₹29 Cr | ₹37 Cr | ₹36 Cr | ₹32 Cr | - |
| Long Term Investment | ₹29 Cr | ₹37 Cr | ₹36 Cr | ₹32 Cr | - |
| Quoted | - | - | - | - | - |
| Unquoted | ₹29 Cr | ₹37 Cr | ₹36 Cr | ₹32 Cr | - |
| Long Term Loans & Advances | ₹44 Cr | ₹29 Cr | ₹18 Cr | ₹10 Cr | - |
| Other Non Current Assets | - | - | - | - | - |
| Total Non-Current Assets | ₹1,584 Cr | ₹1,236 Cr | ₹1,081 Cr | ₹1,012 Cr | - |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹48 Cr | ₹70 Cr | ₹51 Cr | - | - |
| Quoted | ₹41 Cr | ₹61 Cr | ₹28 Cr | - | - |
| Unquoted | ₹7.04 Cr | ₹8.98 Cr | ₹23 Cr | - | - |
| Inventories | ₹588 Cr | ₹643 Cr | ₹602 Cr | ₹475 Cr | - |
| Raw Materials | ₹222 Cr | ₹211 Cr | ₹191 Cr | ₹191 Cr | - |
| Work-in Progress | ₹130 Cr | ₹129 Cr | ₹140 Cr | ₹90 Cr | - |
| Finished Goods | ₹216 Cr | ₹250 Cr | ₹212 Cr | ₹190 Cr | - |
| Packing Materials | - | ₹1.46 Cr | ₹1.89 Cr | ₹1.15 Cr | - |
| Stores  and Spare | ₹4.14 Cr | ₹4.28 Cr | ₹2.72 Cr | ₹2.31 Cr | - |
| Other Inventory | ₹15 Cr | ₹48 Cr | ₹54 Cr | ₹1.05 Cr | - |
| Sundry Debtors | ₹575 Cr | ₹519 Cr | ₹450 Cr | ₹377 Cr | - |
| Debtors more than Six months | ₹8.09 Cr | ₹12 Cr | ₹33 Cr | ₹9.21 Cr | - |
| Debtors Others | ₹570 Cr | ₹510 Cr | ₹419 Cr | ₹367 Cr | - |
| Cash and Bank | ₹8.65 Cr | ₹24 Cr | ₹12 Cr | ₹83 Cr | ₹0.25 Cr |
| Cash in hand | ₹0.14 Cr | ₹0.09 Cr | ₹0.11 Cr | ₹0.06 Cr | - |
| Balances at Bank | ₹8.51 Cr | ₹24 Cr | ₹12 Cr | ₹83 Cr | ₹0.25 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹16 Cr | ₹17 Cr | ₹7.70 Cr | ₹11 Cr | - |
| Interest accrued on Investments | - | - | - | - | - |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | ₹1.11 Cr | ₹2.22 Cr | ₹1.12 Cr | - | - |
| Prepaid Expenses | ₹6.34 Cr | ₹6.15 Cr | ₹2.33 Cr | ₹4.20 Cr | - |
| Other current_assets | ₹8.24 Cr | ₹8.64 Cr | ₹4.26 Cr | ₹6.54 Cr | - |
| Short Term Loans and Advances | ₹87 Cr | ₹72 Cr | ₹40 Cr | ₹82 Cr | - |
| Advances recoverable in cash or in kind | ₹15 Cr | ₹6.58 Cr | ₹3.04 Cr | - | - |
| Advance income tax and TDS | - | ₹3.44 Cr | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹72 Cr | ₹62 Cr | ₹37 Cr | ₹82 Cr | - |
| Total Current Assets | ₹1,322 Cr | ₹1,346 Cr | ₹1,163 Cr | ₹1,028 Cr | ₹0.25 Cr |
| Net Current Assets (Including Current Investments) | ₹665 Cr | ₹651 Cr | ₹562 Cr | ₹447 Cr | ₹0.23 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹2,906 Cr | ₹2,582 Cr | ₹2,244 Cr | ₹2,040 Cr | ₹0.25 Cr |
| Contingent Liabilities | ₹14 Cr | ₹7.19 Cr | ₹6.86 Cr | - | - |
| Total Debt | ₹396 Cr | ₹264 Cr | ₹214 Cr | ₹339 Cr | ₹0.02 Cr |
| Book Value | - | 193.85 | 171.97 | 53,646.60 | 9.12 |
| Adjusted Book Value | 219.36 | 193.85 | 171.97 | 53,646.60 | 9.12 |
Compare Balance Sheet of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹7,828.3 Cr | 1.6% | 4.1% | 31.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | 0.2% | 2.3% | -9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,708.0 Cr | -1.3% | 9.1% | 16.7% | Stock Analytics | |
| CIPLA | ₹121,525.0 Cr | 0.2% | -0.6% | -3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,147.0 Cr | 0.6% | 1% | 10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,596.0 Cr | 0.6% | -3.5% | -4.3% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | 1.6% |
4.1% |
31.2% |
| SENSEX | -1.4% |
1.7% |
4.8% |
You may also like the below Video Courses